MediciNova
Price & Volume
Stats
See moreOpen | $1.85 |
Previous Close | $1.77 |
Day Range | $1.80-$1.85 |
52W Range | $1.12-$2.55 |
Market Cap | $87M |
Shares Short | 315,559 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.21 |
News
See moreYahoo Finance • last year
MediciNova Announces New Data and Results of a Phase 2 Clinical Trial of MN-166 (ibudilast) in Glioblastoma Presented at the 28th Annual Meeting of the Society for Neuro-Oncology
Yahoo Finance • last year
MediciNova’s Collaborator Initiates Clinical Development of a Gene Therapy Product for the Treatment of Phenylketonuria
Yahoo Finance • last year
MediciNova Receives a Notice of Allowance for a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Canada
Yahoo Finance • last year
MediciNova Receives Gene Therapy Milestone Payment
About
CEO | Dr. Yuichi Iwaki M.D., Ph.D. |
CFO | Mr. Jason J. Kruger CPA |
Address | 4275 Executive Square, La Jolla, CA, United States, 92037 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 13 |
